Table 5.

ASFV-G-ΔI177L Licensed Vaccine—Efficacy Studies.

Clinical Model—Efficacy
N	Challenge Route	Challenge Dose	Challenge Strain	Challenge Timpoint (dpv)	Observation Period (dpc)	Readouts	Comments
5	IM	103 HAD50	Georgia	28	21	CS, T, V, TqPCR	proof-of concept [63]
5
5
5		102 HAD50	TTKN/ASFV/ DN/2019	28	15	CS, T, V NS	efficacy in Yorkshire × Landrace crossbreed [64]
25						CS, T
5						CS, T, V, NS	efficacy in Vietnamese Mong Cai crossbreed [64]
5
5
5
20						CS, T
18				14	14	CS, T	efficacy in Yorkshire × Landrace and Vietnamese Mong Cai crossbreed [64]
5				21
10				28

Readouts: CS = clinical signs, T = temperature, V = viremia, NS = nasal swab, TqPCR = tissue qPCR.